Superb Micro-vascular Imaging for Evaluation of Hepatic Lesions

Zhejiang University

Status: Unknown

Conditions: Hepatic Lesion

Treatments: Device: Superb-Microvascular imaging

Study type: Observational

Funder types: Other

Identifiers

NCT04917354

2017-025

Details and patient eligibility

About

Superb Micro-vascular Imaging (SMI) based on the iBeam platform is used to evaluate the blood supply of solid tumors. Compared with color Doppler technology, the sensitivity, accuracy and consistency of the ability of SMI to display blood flow are evaluated. Thus, the investigators will use Superb-Microvascular imaging (SMI, Toshiba, Japan) for diagnosing hepatic lesions, which enable to detect slow micro vascular flow inside the tumor

Full description

To evaluate the diagnostic accuracy of SMI (primary outcome) when applying on the hepatic lesion.

Each US findings during exam for patients with hepatic lesion were recorded by radiologist.

Sample size calculation according to the primary outcome.

Enrollment: 150 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Visible hepatic lesion on US
2. Agree to participate in the study
3. Accessible follow-up imaging or pathological results

Exclusion criteria

1. Pregnant women

Trial design

150 participants in 1 patient group

hepatic lesion

Treatment:

Device: Superb-Microvascular imaging